Year All2026202520242023202220212020201920182017 May 14, 2026 Personalis to Participate in Upcoming Investor Events Read More May 13, 2026 Personalis Receives Medicare Coverage for NeXT Personal® for Immunotherapy Monitoring Across Late-stage Solid Tumors Read More May 7, 2026 Personalis Reports First Quarter Results and Recent Highlights Read More April 23, 2026 Personalis to Announce First Quarter 2026 Financial Results Read More April 21, 2026 Personalis Highlights Clinical Impact of Ultrasensitive ctDNA Monitoring and New Therapy Resistance Tracking at AACR 2026 Read More April 13, 2026 Personalis and Collaborators to Highlight Ultrasensitive ctDNA Data and New Therapy Resistance Tracking Capabilities at AACR 2026 Read More April 1, 2026 Personalis to Participate in the 25th Annual Needham Virtual Conference Read More March 17, 2026 Personalis Appoints Dr. Richard Chen as President to Further Accelerate MRD Adoption Read More March 12, 2026 Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal® Read More February 26, 2026 Personalis Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights Read More